– Lorundrostat, a highly selective aldosterone synthase inhibitor, demonstrated robust, double-digit reduction in systolic blood…
Topline results from Phase IV study demonstrate Qelbree is safe and well-tolerated, and significantly improved…
HONG KONG, Sep 10, 2023 – (ACN Newswire) – The physical exhibitions of the 42nd…
Hargroves Helping Hand Media-Group announces omnichannel marketing strategies for qualifying businesses to help them gain…
TEL AVIV, Israel–(BUSINESS WIRE)–ARX Advisory LTD, a leading data-backed capital markets advisory, proudly announces its…
NEW YORK–(BUSINESS WIRE)–VanEck announced today that it plans to close and liquidate one of its…
Only 2% of homeowners with a mortgage were in negative equity as of the second…
Reserves at Valencia Crossing offers personalized, new, single-story homes close to shopping, dining and entertainment…
JAKARTA, Sep 9, 2023 – (ACN Newswire) – Through the ASEAN-Indo-Pacific Forum (AIPF) held in…
JAKARTA, Sep 9, 2023 – (ACN Newswire) – Indonesia identified cooperation projects worth US$32 billion…
On September 7th, the FF 91 2.0 Futurist Alliance broke the fastest lap record in…
Property Deal Network in category “Networking Event” and ACDS in category “Commercial Finance Broker” have…
NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at…
NEW YORK–(BUSINESS WIRE)–#KBRA–On June 21, 2023, KBRA affirmed the senior unsecured debt rating of BBB+,…
NEW YORK–(BUSINESS WIRE)–#KBRA–On August 18, 2023, KBRA affirmed the issuer rating of BBB- for Private…
University of Phoenix Adopts Comprehensive Guidelines for Responsible Student Use of Generative AI PHOENIX–(BUSINESS WIRE)–The…
— CEO highlights customer interest in AI-powered innovation, migration “at their pace to the cloud,”…
Robert E. Landry to retire effective February 2024; Christopher Fenimore, long-standing Senior Vice President, Head…
Robert E. Landry to retire effective February 2024; Christopher Fenimore, long-standing Senior Vice President, Head…
Kathryn Guarini, Ph.D., and David P. Schenkein, M.D., join Regeneron’s Board of Directors TARRYTOWN, N.Y.,…